Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Deafness | frequent | x | x | |
Nausea | common | x | x | |
Vertigo | common | x | x | |
Vomiting | common | x | x | |
Ototoxicity | common, frequent | x | x | |
Amblyopia | x | x | ||
Anaphylactic shock | x | x | ||
Haemolytic anaemia | x | x | ||
Angioedema | x | x | ||
Dermatitis exfoliative | x | x | ||
Eosinophilia | x | x | ||
Rash | x | x | ||
Body temperature increased | x | x | ||
Leukopenia | x | x | ||
Pancytopenia | x | x | ||
Paraesthesia | x | x | ||
Thrombocytopenia | x | x | ||
Urticaria | x | x | ||
Muscular weakness | x | x | ||
Azotaemia | x | x | ||
Unable to walk | x | x | ||
Nephrotoxicity | x | x | ||
Renal impairment | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |